Epstein Secrets

egulatory covalence; former Medical Officer & Dep. Director at FDA) • Paul Flyer, PhD, Dinka( Stan sacs 135• years of statistical experience - FDA, Amgen, Biogen Ides. ICOS) • Solomon Tse, PhD, Chemistry, Manufacturing, & Controls (30• years OMC experience- MJ) • Dan Szeto, PhD, OA/QC pa years QC/Q

s virus In vivo • EPB-348 is more effective against SW in a monkey infection model compared to ACV Clinical • Phase 2a clinical shingles trial (Abbott) • Study showed a 10% decrease In pain duration with 750 mg BID, compared to acyclovir Parameter EP8-348 230 mg Take a day EPB-348 MO mg Twi

irus IEBV), & Herpes Simplex 1 and 2 (HSV-1/2) History of Valomadclovir Stearate (EPB-348) • EPB-348 invented by MedMr AB (MIV.606) • Ucensed to Abbott laboratories- developed through Phase 2a (ABT-606) • Ucensed to Reliant Pharmaceuticals -developed tablet formulation (RP-606) • Ucensed to Epiph

t and XDx, while maintaining board observer status with Labcyte. Vijay was previously on the boards of Advanced Cell Diagnostics, Ilypsa (acquired by Amgen) and Relypsa (NASDAQ: RLYP). Prior to joining Sprout, Vijay spent one year as an analyst in the healthcare venture capital group at Robertson Stephen

quently split to become 2 separate companies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilypsa (Sprout IX, exited in sale to Amgen, 6.9x multiple). e Established Private Companies: The New Leaf Team has played the role of lead investor in a large number of private investments. T

She was previously on the boards of directors of Interlace (NLV-I company acquired by Hologic), Epicor (acquired by St. Jude), Visiogen (acquired by Abbott), PercuSurge (acquired by Medtronic), and NxStage Medical (NASDAQ: NXTM). Prior to joining the healthcare investment team at Sprout, Jeani was a Gene

a division, sending the case to Illinois, where Zebra is headquartered. Order attached I Read full article » MERGERS & ACQUISITIONS 5 Firms Shape Amgen's $13.4B Celgene Drug Buy Amgen will shell out $13.4 billion in cash to snap up Celgene's psoriasis and psoriatic arthritis drug, a deal shaped by

has been confirmed to the federal bench will be filled by a former state appellate judge and current Vinson & Elkins LLP attorney, Texas Gov. Greg Abbott said Monday. Read full article » Former Bryan Cave Partner Appointed Cred General Counsel Cryptocurrency lending and borrowing company Cred has hi